InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

BIOCRYST PHARMACEUTICALS INC

BCRX Clue Score70
United States Fiscal year ends December CIK 0000882796 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

21
Insider
Date
Role
Action
Shares
Price
Amount
Jon P Stonehouse
2 Mar 2026
Director
Exercised, kept
305,995
$3.22
$985.30K
Charles K Gayer
22 Dec 2025
President and CCO
Exercised, kept
50,000
$5.51
$275.50K
Charles K Gayer
22 Dec 2025
President and CCO
Exercised, kept
10,091
$5.04
$50.86K
Charles K Gayer
22 Dec 2025
President and CCO
Exercised, kept
14,142
$3.22
$45.54K
Jon P Stonehouse
21 Mar 2023
President & CEO
Exercised, kept
31,055
$3.22
$100.00K
Kenneth B Lee Jr
31 Jan 2023
Director
Exercised, kept
15,000
$1.71
$25.65K
Alane P Barnes
12 May 2021
Chief Legal Officer
Exercised, kept
35,852
$4.73
$169.58K
Michael L Jones
18 Mar 2021
Exec. Director, Finance - PAO
Exercised, kept
4,500
$3.51
$15.80K
Yarlagadda S Babu
19 Feb 2021
Senior VP - Drug Discovery
Exercised, kept
50,000
$4.15
$207.50K
Yarlagadda S Babu
31 Jan 2019
Senior VP - Drug Discovery
Exercised, kept
12,188
$1.20
$14.63K
Yarlagadda S Babu
31 Jan 2019
Senior VP - Drug Discovery
Exercised, kept
19,686
$1.20
$23.62K
Stanley C Erck
28 Nov 2018
Director
Exercised, kept
8,333
$1.49
$12.42K
Jon P Stonehouse
17 May 2018
President & CEO
Exercised, kept
70,427
$1.42
$100.01K
Alane P Barnes
15 May 2018
VP, General Counsel & Corp Sec
Exercised, kept
12,500
$1.42
$17.75K
Yarlagadda S Babu
6 Mar 2018
Senior VP - Drug Discovery
Exercised, kept
9,378
$3.26
$30.57K
Yarlagadda S Babu
6 Mar 2018
Senior VP - Drug Discovery
Exercised, kept
20,622
$3.26
$67.23K
Alane P Barnes
28 Feb 2018
VP, General Counsel & Corp Sec
Exercised, kept
6,709
$3.26
$21.87K
Jon P Stonehouse
28 Feb 2018
President & CEO
Exercised, kept
56,949
$3.26
$185.65K
Thomas R Staab II
22 May 2017
Senior Vice President and CFO
Exercised, kept
7,750
$4.73
$36.66K
Thomas R Staab II
16 Mar 2017
Senior Vice President and CFO
Exercised, kept
12,500
$1.42
$17.75K
Thomas R Staab II
16 Mar 2017
Senior Vice President and CFO
Exercised, kept
23,955
$3.78
$90.55K
Show all 159 transactions →

What was left out

Form 4 filings counted 457
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 86
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 8,263,448
Sales filed before the plan box existed 15
History held since 3 Nov 2006